Exicure Inc. [NASDAQ: XCUR] jumped around 0.0 points on Friday, while shares priced at $0.12 at the close of the session, up 6.70%. The company report on May 10, 2022 that Exicure Announces $5 Million Raise in Private Placement Transaction Priced at Market Premium.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
Proceeds expected to support Exicure’s continued advancement of preclinical candidates including its SCN9A product candidate, a non-opioid pain analgesic.
The private placement is being led by a subsidiary of CBI Co., Ltd. (“CBI”), a member of a leading investment group in South Korea focusing on science-based companies in South Korea and the United States.
Exicure Inc. stock is now -39.29% down from its year-to-date (YTD) trading value. XCUR Stock saw the intraday high of $0.1259 and lowest of $0.1162 per share. The company’s 52-week high price is 1.98, which means current price is +29.16% above from all time high which was touched on 03/22/22.
Compared to the average trading volume of 11.82M shares, XCUR reached a trading volume of 11811911 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Exicure Inc. [XCUR]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for XCUR shares is $3.13 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on XCUR stock is a recommendation set at 2.50. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Chardan Capital Markets have made an estimate for Exicure Inc. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on December 13, 2021. While these analysts kept the previous recommendation, BMO Capital Markets raised their target price to Outperform. The new note on the price target was released on December 18, 2020, representing the official price target for Exicure Inc. stock. Previously, the target price had yet another raise to $9, while Guggenheim analysts kept a Buy rating on XCUR stock.
The Average True Range (ATR) for Exicure Inc. is set at 0.02 The Price to Book ratio for the last quarter was 1.02, with the Price to Cash per share for the same quarter was set at 0.34.
How has XCUR stock performed recently?
Exicure Inc. [XCUR] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -0.97. With this latest performance, XCUR shares dropped by -33.68% in over the last four-week period, additionally sinking by -89.04% over the last 6 months – not to mention a drop of -91.74% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for XCUR stock in for the last two-week period is set at 39.49, with the RSI for the last a single of trading hit 41.00, and the three-weeks RSI is set at 40.01 for Exicure Inc. [XCUR]. The present Moving Average for the last 50 days of trading for this stock 0.1907, while it was recorded at 0.1116 for the last single week of trading, and 0.6230 for the last 200 days.
Exicure Inc. [XCUR]: Deeper insight into the fundamentals
Return on Equity for this stock declined to -176.25, with Return on Assets sitting at -77.55.
Exicure Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.30 and a Current Ratio set at 1.30.
Insider trade positions for Exicure Inc. [XCUR]
There are presently around $5 million, or 33.30% of XCUR stock, in the hands of institutional investors. The top three institutional holders of XCUR stocks are: ARMISTICE CAPITAL, LLC with ownership of 8,602,643, which is approximately New of the company’s market cap and around 4.20% of the total institutional ownership; TYBOURNE CAPITAL MANAGEMENT (HK) LTD, holding 7,325,000 shares of the stock with an approximate value of $0.9 million in XCUR stocks shares; and ABINGWORTH LLP, currently with $0.86 million in XCUR stock with ownership of nearly 0% of the company’s market capitalization.
Positions in Exicure Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 18 institutional holders increased their position in Exicure Inc. [NASDAQ:XCUR] by around 12,276,817 shares. Additionally, 21 investors decreased positions by around 7,989,086 shares, while 19 investors held positions by with 18,897,712 shares. The mentioned changes placed institutional holdings at 39,163,615 shares, according to the latest SEC report filing. XCUR stock had 8 new institutional investments in for a total of 10,019,697 shares, while 12 institutional investors sold positions of 3,157,339 shares during the same period.